Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of lifeReportar como inadecuado




Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Pediatric Rheumatology

, 11:23

First Online: 28 May 2013Received: 07 March 2013Accepted: 20 May 2013

Abstract

BackgroundChildren who take methotrexate for juvenile idiopathic arthritis may experience side effects, including nausea and vomiting, leading to anticipatory nausea in some children, and fear of injections or blood tests. The aim of this study was to examine the prevalence and extent of these difficulties and their impact on quality of life.

MethodsParticipants were mothers of children with JIA who were currently taking methotrexate MTX. Mothers completed a questionnaire about MTX that was developed for the study, two questions from the treatment subscale of the Pediatric Quality of Life Inventory PedsQL Rheumatology scale to assess needle-related problems and the Child Health Questionnaire 50-item parent version CHQ-PF50 to assess health-related quality of life HRQoL.

Results171 mothers participated in the study. More than half of children were reported to have experienced one or more of: nausea or vomiting after taking MTX, anticipatory nausea, fear of blood tests or fear of injections. There was no significant difference in reported rates of sickness or needle-related problems between MTX responders ACR70 or above, partial responders ACR30 or ACR50 and non-responders. In multivariate analyses, variables that were significant independent predictors of one or more MTX-related difficulties included younger age, taking MTX subcutaneously and having a larger number of currently active joints. Feeling sick after taking MTX was a significant independent predictor of poorer scores on the physical summary scale of the CHQ-PF50. Anxiety about injections and feeling sick after taking MTX were significant independent predictors of poorer scores on the psychosocial summary scale.

ConclusionsDifficulties in taking MTX are experienced by a significant proportion of children with JIA and these may have an adverse impact on HRQoL. Approaches to help minimize these difficulties are required.

KeywordsJuvenile idiopathic arthritis Methotrexate Side effects Intolerance Anticipatory nausea Psychological Quality of life Electronic supplementary materialThe online version of this article doi:10.1186-1546-0096-11-23 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Autor: Kathleen Mulligan - Laura Kassoumeri - Angela Etheridge - Halima Moncrieffe - Lucy R Wedderburn - Stanton Newman

Fuente: https://link.springer.com/







Documentos relacionados